SEC Filings for Actinium Pharmaceuticals Inc. (Delaware) (ATNM)

$ 0.2049   0.0043 (+2.14%) Volume: 698.38k 12:59 PM EDT 31-Mar-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
DEFA14AAdditional proxy soliciting materials - definitive211/30/2016
DEF 14AOther definitive proxy statements19711/18/2016
10-QGeneral form for quarterly reports under Section 13 or 15(d)4410/28/2016
424B5Prospectus [Rule 424(b)(5)]6909/29/2016
8-KCurrent report pursuant to Section 13 or 15(d)4409/29/2016
424B5Prospectus [Rule 424(b)(5)]6909/28/2016
SC 13GStatement of acquisition of beneficial ownership by individuals109/15/2016
4Statement of changes in beneficial ownership of securities109/01/2016
4Statement of changes in beneficial ownership of securities108/30/2016
4Statement of changes in beneficial ownership of securities108/17/2016
8-KCurrent report pursuant to Section 13 or 15(d)708/04/2016
10-QGeneral form for quarterly reports under Section 13 or 15(d)4407/29/2016
4Statement of changes in beneficial ownership of securities107/14/2016
4Statement of changes in beneficial ownership of securities107/12/2016
4Statement of changes in beneficial ownership of securities107/07/2016
34567891011121314151617